Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current LiabilitiesPayablesPreferred SharesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

INVO Fertility (IVF) Other Accumulated Expenses (2023 - 2025)

Historic Other Accumulated Expenses for INVO Fertility (IVF) over the last 6 years, with Q3 2025 value amounting to $10500.0.

  • INVO Fertility's Other Accumulated Expenses fell 9700.0% to $10500.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $10500.0, marking a year-over-year decrease of 9700.0%. This contributed to the annual value of $410000.0 for FY2024, which is 1714.29% up from last year.
  • As of Q3 2025, INVO Fertility's Other Accumulated Expenses stood at $10500.0, which was down 9700.0% from $10500.0 recorded in Q2 2025.
  • INVO Fertility's 5-year Other Accumulated Expenses high stood at $715245.0 for Q1 2025, and its period low was $10500.0 during Q2 2025.
  • In the last 3 years, INVO Fertility's Other Accumulated Expenses had a median value of $350000.0 in 2023 and averaged $296630.8.
  • Per our database at Business Quant, INVO Fertility's Other Accumulated Expenses soared by 18355.69% in 2024 and then tumbled by 9700.0% in 2025.
  • Quarter analysis of 3 years shows INVO Fertility's Other Accumulated Expenses stood at $350000.0 in 2023, then increased by 17.14% to $410000.0 in 2024, then tumbled by 97.44% to $10500.0 in 2025.
  • Its last three reported values are $10500.0 in Q3 2025, $10500.0 for Q2 2025, and $715245.0 during Q1 2025.